Test Price
2,800 AED✅ Home Collection Available
CARD14 Gene Psoriasis Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CARD14 للصدفية من النوع الثاني بتقنية التسلسل الجيني NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Trust Commitment
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital-Grade Home Collection (8 AM – 11 PM) with ISO‑Certified Cold‑Chain Transport. VIP Mobile Phlebotomy included.
- Clinical Guidance: Post‑Test Telephonic Interpretation by DHA‑Licensed Specialists (Dermatology, Clinical Genetics).
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
الفحص الجيني لجين CARD14 للصدفية من النوع الثاني بتقنية الجيل التالي (NGS): دقة تشخيصية 99.9%، مع معالجة معتمدة آيزو واستشارة طبية عن بُعد تشمل الإرشاد الوراثي. خدمة سحب منزلي فاخرة ودعم تأميني فوري.
Overview of CARD14 Psoriasis Type 2 Gene Test
The CARD14 Psoriasis Type 2 Genetic Test analyses the entire coding region of the CARD14 gene using Next‑Generation Sequencing (NGS) to identify pathogenic variants linked to plaque psoriasis and psoriatic arthritis. In the UAE, this definitive molecular assay supports clinical diagnosis, familial risk assessment, and personalised biologic therapy selection. يكشف هذا الاختبار الطفرات الوراثية في جين CARD14 بدقة عالية لدعم التشخيص المبكر واختيار العلاج البيولوجي الأنسب.
| Feature | Our CARD14 NGS Test | Closest Alternative (Standard Psoriasis Panel) |
|---|---|---|
| Method | Full‑Gene Next‑Generation Sequencing (NGS) | Limited SNP genotyping or exome slice |
| Diagnostic Precision | >99.9% sensitivity for coding variants | May miss rare or novel CARD14 mutations |
| Turnaround Time | 3–4 Weeks (ISO‑lab validated) | Often 5–6 Weeks (overseas processing) |
| Reporting | Clinically annotated report + DHA‑authorised genetic counselling | Raw variant list without UAE‑specific therapeutic correlation |
Physician Insight & Safety Protocol
“As a Dermatologist with over two decades of clinical experience, I emphasise that a positive CARD14 variant is not a standalone diagnosis but a powerful piece of the puzzle. This test, when interpreted alongside your clinical history and family pedigree, can illuminate the road toward targeted biologic therapy and early intervention for psoriatic arthritis. I remain committed to guiding you through the results with empathy and precision.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
⚠️ Medication Warning:
Do not discontinue any prescribed systemic medication (including methotrexate, biologics, or corticosteroids) without consulting your treating physician. Genetic results must be integrated with ongoing clinical care.
Patient Safety & Exclusion Criteria
- This test is not intended for acute emergency diagnosis of pustular psoriasis flare requiring immediate hospitalisation.
- Minors (<18 years) must have consent from a legal guardian in accordance with UAE Federal CDS Law 2026 and Decree‑Law No. 41 of 2024 (Art. 87).
- If you experience sudden widespread pustulation, high fever, or joint swelling, seek urgent medical care—do not wait for genetic results.
- Genetic counselling is mandatory prior to sample collection; our team will schedule a session.
Patient FAQ & Clinical Guidance
1. Can a CARD14 gene test predict the severity of my psoriasis?
🔹 Snippet: Yes, certain CARD14 mutations strongly correlate with early‑onset, treatment‑resistant plaque psoriasis and an elevated risk for psoriatic arthritis.
While the test identifies pathogenic variants, it cannot quantify day‑to‑day severity; clinical assessment remains essential. The result informs your dermatologist about potential biologic targets (e.g., IL‑17/IL‑23 inhibitors) and allows preventive joint screening.
نعم، بعض طفرات جين CARD14 ترتبط ارتباطاً وثيقاً بصدفية مبكرة مقاومة للعلاج مع خطر متزايد لإصابة المفاصل، مما يساعد في توجيه العلاج البيولوجي والمراقبة الاستباقية.
2. What sample is required and how long do results take?
🔹 Snippet: A single blood draw, dried blood spot on FTA card, or previously extracted DNA suffices; reports are ready in 3–4 weeks.
Our home collection team arrives with all ISO‑controlled materials. Once the sample reaches our DHA‑licensed laboratory, full NGS sequencing and bioinformatic analysis proceed. The final report includes a clinical interpretation and is released after genetic counselling.
عينة دم واحدة أو بقعة دم جافة على بطاقة FTA أو حمض نووي مستخلص مسبقاً. تصدر النتائج خلال 3 إلى 4 أسابيع مع تقرير سريري وجلسة إرشاد وراثي.
3. Is this genetic test covered by UAE insurance?
🔹 Snippet: Many UAE insurers reimburse the CARD14 when requested by a DHA‑licensed dermatologist for medically necessary psoriasis typing.
Our patient support team directly verifies your coverage with leading payers (e.g., Daman, AXA, Neuron) via WhatsApp. We handle all pre‑approval paperwork to ensure a seamless, transparent billing experience. If self‑pay, a 2800 AED all‑inclusive price applies.
نعم، تغطي العديد من شركات التأمين الإماراتية هذا الفحص بوصفة طبية من طبيب أمراض جلدية مرخص. فريقنا يُكمل إجراءات الموافقة المسبقة عبر واتساب.
UAE Regulatory Framework: This genetic service fully complies with Federal Decree‑Law No. 41 of 2024 on Genetic Testing (Art. 87), CDS Law 2026 protecting minors, and UAE PDPL for personal data privacy. All testing is performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). DHA facility license: 9834453. Medical oversight by Dr. PRABHAKAR REDDY (DHA 61713011).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians